treatment-free intervals: what is best for patients?
Published 2 years ago • 45 plays • Length 4:02Download video MP4
Download video MP3
Similar videos
-
4:10
treatment-free intervals for patients with myeloma
-
0:45
current landscape of treatment for scd: an update from ash 2023
-
2:02
rwd from insight-mm: duration of therapy and treatment sequencing
-
1:23
developing a pro collection tool for patients with scd: key themes which are important to patients
-
1:09
emerging treatment options for refractory immune thrombocytopenia
-
19:39
t-cell engagers: targets, challenges and opportunity
-
26:17
la leucemia acuta promielocitica - maria teresa voso
-
5:21
challenges in the treatment and management of et and the need to improve therapeutic approaches
-
4:49
best practices for vaccines after sct and cellular therapy & the role of pharmacists in this process
-
3:09
treatment strategies for chl patients after auto-hsct
-
2:12
treatment choice for mm in uk practice
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
2:42
the potential for a chemotherapy-free strategy in all
-
8:13
treatment strategies for high-risk mm
-
0:52
mrd for multiple myeloma: is it ready for prime-time?
-
2:14
updates on the smart stop trial: the potential for a chemo-free regimen in the frontline for dlbcl
-
1:52
cytoreductive therapy for patients with pv
-
2:25
a final update of enhance: reflecting on the negative read-out of the study
-
4:29
smoldering myeloma: monitoring patients and deciding when to treat
-
1:02
emerging treatment options for lower- and higher-risk mds and ongoing trials
-
8:26
triple combination therapies for multiple myeloma (mm) patients